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The crystal structure of human 
Rogdi provides insight into the 
causes of Kohlschutter-Tönz 
Syndrome
Hakbong Lee1,4, Hanbin Jeong1,4, Joonho Choe2, Youngsoo Jun3,4, Chunghun Lim1 & 
Changwook Lee1,4
Kohlschutter-Tönz syndrome (KTS) is a rare autosomal-recessive disorder of childhood onset 
characterized by global developmental delay, spasticity, epilepsy, and amelogenesis imperfecta. 
Rogdi, an essential protein, is highly conserved across metazoans, and mutations in Rogdi are linked 
to KTS. However, how certain mutations in Rogdi abolish its physiological functions and cause KTS 
is not known. In this study, we determined the crystal structure of human Rogdi protein at atomic 
resolution. Rogdi forms a novel elongated curved structure comprising the α domain, a leucine-zipper-
like four-helix bundle, and a characteristic β-sheet domain. Within the α domain, the N-terminal H1 
helix (residues 19–45) pairs with the C-terminal H6 helix (residues 252–287) in an antiparallel manner, 
indicating that the integrity of the four-helix bundle requires both N- and C-terminal residues. The 
crystal structure, in conjunction with biochemical data, indicates that the α domain might undergo a 
conformational change and provide a structural platform for protein–protein interactions. Disruption 
of the four-helix bundle by mutation results in significant destabilization of the structure. This 
study provides structural insights into how certain mutations in Rogdi affect its structure and cause 
KTS, which has important implications for the development of pharmaceutical agents against this 
debilitating neurological disease.
Genetic mutations often affect the structure of the encoded protein, resulting in structural disruption and, in 
some cases, disease. For example, sickle cell disease is caused by a single point mutation in the sixth codon of the 
β-globin gene1–3. A change from glutamic acid to valine induces a structural change in red blood cells that conse-
quently adopt a sickle-like shape, and their physiological function is compromised. Similarly, a polymorphism in 
apolipoprotein E (APOE), a major cholesterol carrier, also demonstrates a cause-and-effect relationship between 
genetic risk and disease. APOE4, unlike other APOE alleles, has an arginine at residue 112, and the structure of 
APOE4 is more stable than other isoforms due to the formation of an additional salt bridge involving this resi-
due4, 5. This structural feature of APOE4 affects its ability to bind lipids or β-amyloids (Aβ), and contributes to 
Alzheimer’s disease pathogenesis in an Aβ-dependent manner, although the exact mechanism is not completely 
understood6.
Kohlschutter-Tönz syndrome (KTS) is a rare genetic disorder characterized by severe global developmen-
tal delay, epilepsy, amelogenesis imperfecta, psychomotor delay or regression starting early in childhood, and 
intellectual disability7–12. Amelogenesis imperfecta, the most striking feature of KTS, is used as a clinical marker, 
which is most obviously observed as yellowed teeth and abnormal enamel7. The molecular cause of KTS has not 
yet been elucidated. However, recent genetic studies using a combination of whole-exome sequencing, autozygo-
sity mapping, linkage analysis, and Sanger sequencing revealed that KTS is caused by putative loss-of-function 
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mutations in the ROGDI gene on chromosome 16p13.313–16. Mutations causing KTS include the premature termi-
nation of translation of Rogdi, a homozygous frameshift deletion, and an abnormal splicing error.
Rogdi is the human homolog of Drosophila melanogaster rogdi, and is a predicted leucine zipper protein of 
unknown function13. The protein is present in metazoan species ranging from worms to humans, and is highly 
conserved across taxa, indicating an essential functional role that is evolutionarily conserved. A previous study 
revealed that Rogdi is widely expressed, with particularly high expression in the adult brain, spinal cord, periph-
eral blood, heart, and bone marrow, suggesting an involvement in neurogenesis13. This is supported by data show-
ing that Rogdi directly interacts with DISC1, which is necessary for neuronal proliferation, migration in cerebral 
interneurons, and their proper differentiation in the cerebral cortex13, 17, 18. Another study indicates an important 
role in tumorigenesis and the cell death mechanism in cervical cancer cells, in which knockdown of the ROGDI 
gene leads to increased p53 and p21 protein levels and downregulation of CDK1 and CDK219, 20.
Although the genetic causes of ROGDI mutants in KTS patients are relatively well established, the molecular 
basis by which specific mutations abolish protein function and cause KTS has not yet been elucidated. Herein, we 
report the atomic resolution structure of the human Rogdi protein for the first time. Combined with biochemical 
data, the structure provides insight into the link between Rogdi mutants and KTS at the molecular level.
Results
Crystal Structure Determination. The human Rogdi protein comprises 287 residues, and is highly con-
served among species including fish, fly, frog, worm, and mouse (Fig. 1). To gain structural insight into Rogdi 
mutations and their link to KTS, we crystallized human Rogdi. Native crystals of the full-length protein grew in 
space group R3 and diffracted to 2.8 Å resolution using a synchrotron radiation source. However, we were unsuc-
cessful in producing full-length selenomethionine (Se-Met) derivatized protein, due to poor protein expression 
in the methionine auxotrophic bacteria. Instead, Se-Met substituted Rogdi was produced and crystallized using 
N- and C-terminally truncated constructs (residues 11–276, referred to as tRogdi). The structure of tRogdi was 
determined by single-wavelength anomalous dispersion (SAD) and refined to 2.04 Å resolution. The structure of 
full-length Rogdi was determined by molecular replacement using the tRogdi structure as a search model and 
refined to 2.8 Å resolution, with Rwork/Rfree values of 21.9/26.8% (Fig. S1). Statistics for data collection and refine-
ment are presented in Table 1.
The structures of full-length and truncated Rogdi are almost identical, with a root mean square devia-
tion (RMSD) of 0.8 Å for all Cα atoms. Therefore, we discuss only the full-length Rogdi structure. Crystals of 
full-length Rogdi contain four molecules in the asymmetric unit. Interestingly, there are two conformations 
among the four molecules, with structural differences mainly at the N-terminus (residues 1–14), presumably 
due to crystal packing. The electron density at the N-terminal region is relatively well ordered in both confor-
mations. Residues 1–14 in the two molecules fold into an α-helix (designated as RogdiH), extending the α-helix 
to residue 45, while the same regions in the remaining two molecules are unfolded and form a long loop (desig-
nated as RogdiL), suggesting that this region might be flexible in solution. Consistent with this observation, the 
N-terminus of Rogdi is vulnerable to proteolytic degradation (Fig. 1B). The structure of the two RogdiH molecules 
and the two RogdiL molecules are almost identical, with RMSD values of 0.4 and 0.2 Å for all Cα atoms. The three 
loop regions (residues 64–68, 92–96, and 212–221) are disordered in the two RogdiH molecules; however, the 
electron density for RogdiL is relatively well ordered throughout the protein chain. Apart from in these regions, no 
structural differences between RogdiH and RogdiL were apparent, as reflected by the RMSD values of 1.5 Å for 236 
out of 255 aligned Cα atoms. The N-terminal amino acids 48–55, which correspond to the direct linker between 
H1 and S1 in all molecules including tRogdi, RogdiH, and RogdiL, were not visible in the electron density map, 
indicating high flexibility.
Structure of Human Rogdi. Molecular models of Rogdi are presented in Fig. 2 and S1. The crystal struc-
ture shows that Rogdi resembles a boomerang with an elongated curved structure comprising two distinct α 
and β domains. The α domain consists of four helices (H1 to H3, and H6) that form a left-handed four-helix 
bundle through van der Waals interactions. Overall, the α domain is a compact rod of 75 Å in length and 25 Å in 
diameter. The four helices lie in an anti-parallel orientation, with their axes almost parallel to each other, and a 
hydrophobic core lies buried within. In the four-helix bundle, H2 and H3 are connected to each other via a rela-
tively short loop (residues 129–139), forming a helix-loop-helix structure. By contrast, the secondary structural 
elements between H1 and H2 and between H3 and H6 are not directly linked by short loops, and are instead 
separated by a β domain. However, the α domain is not completely isolated from the β domain in terms of the pri-
mary structure of Rogdi. Although the H1 helix starts from the N-terminus (residue 1), the first α-helix involved 
in forming the four-helix bundle starts from residue 19. Residues 1–18 of helix H1 are not directly involved in 
forming the four-helix bundle structure, consistent with a high degree of flexibility for this region, as indicated in 
the crystal structure and by the limited proteolysis results. The H1 helix of the four-helix bundle starts at residue 
19 and ends at residue 45, and its adjacent anti-parallel paired helix (H6) begins from residue 252 and ends at the 
C-terminus (residue 287). Therefore, the α domain spans from the N-terminus to the C-terminal of the Rogdi 
sequence (Fig. 1A and 2B).
The β domain adopts a β-sandwich structure comprising two β-sheets that are stacked layer in a layer and 
twisted anticlockwise relative to each other. Both β-sheets contain four (S1 to S4 and S5 to S8) anti-parallel 
β-strands, and are flanked by two short α-helices (H4 and H5). The first sheet forms a canonical up-and-down 
anti-parallel β-strand structure. The second β-sheet folds into a more unique structure by combining a β-hairpin 
structure consisting of S5 and S6 with a Greek key-like motif comprising S6 to S8 plus a flexible loop (residues 
209 to 228)21. Overall, the β domain has eight anti-parallel β-strands and two α-helices, which are packed into a 
compact domain with dimensions of 40 Å × 28 Å × 33 Å.
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 3972  | DOI:10.1038/s41598-017-04120-x
The α and β domains are not separated from each other, but rather are tightly packed together. In particu-
lar, the β-hairpin structures of each sheet are embedded in a crevice formed by one end of the two anti-parallel 
α-helices. To form the tight association, Leu 77 and Ile 194 from the β-strands are inserted into the center of 
the interface and form hydrophobic interactions with Phe 45 of helix H1, Leu 110 and Ile 113 of helix H2, Leu 
Figure 1. Domain Structure of Rogdi. (A) Diagram showing the domain structure of human Rogdi as defined 
by structural analysis. The crystal structures of full-length and truncated Rogdi (tRogdi, residues 11–276) were 
determined in this study. Two representative mutants causing KTS are shown to compare the domain structure 
of wild-type and mutant proteins. (B) Protease digestion of full-length Rogdi by trypsin. Rogdi was mixed with 
trypsin at the indicated trypsin:Rogdi ratio for 1 h at 4 °C. Reactions were stopped by adding SDS sample buffer, 
and the products were separated by SDS-PAGE. The two resistant fragments, indicated by red and blue arrows, 
were subjected to N-terminal sequencing. (C) Sequence alignment of Rogdi from six species (H. sapiens, M. 
musculus, X. laevis, D. rerio, D. melanogaster, and C. elegans). Secondary structural elements are indicated above 
the sequences, with helices depicted as cylinders and strands as arrows. Conserved residues (five out of six 
organisms) are highlighted in blue. The repeated heptad leucine residues in H1 and H6, which were predicted to 
form a leucine zipper motif, are indicated by a red box.
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160 of helix H3, and Trp 253 and Leu 254 of helix H6 from the α domain. These interacting residues are highly 
conserved, suggesting that the van der Waals contacts between α and β domains are preserved among different 
species. In addition to hydrophobic interactions, the side chains of Asp 80 and Asn 197 in the β-hairpin engage 
in hydrogen bonds with the side chains of residues Arg 117 and Asn 255 from the α domain helices (Fig. 2D).
According to the UniProtKB/Swiss-Prot report (ID: Q9GZN7), one polymorphism (E59K, p.Glu59Lys) has 
been identified in human Rogdi. We investigated the position of this residue in our crystal structure, and found 
that it (Glu59) is located at the end of the loop generated between H1 helix and β1 strand (Fig. 1C and 2D). The 
side chain of Glu59 projects toward the protein surface, and is not directly involved in interactions with other 
residues. Furthermore, the residue is not conserved in C. elegans (Fig. 1C). Based on these considerations, we 
conclude that it is unlikely that the E59K polymorphism affects the overall structure or functions of Rogdi.
The α Domain of Rogdi adopts a Leucine Zipper-Like Structure. Rogdi is a predicted leucine zipper 
(ZIP) protein based on sequence analysis, which reveals a periodic repetition in leucine residues at every seventh 
position. Most heptad leucine residues are in the N-terminal region, specifically residues 15 to 47, but residues 
251 to 282 are near the C-terminus (Fig. 1C). However, the crystal structure reveals that full-length Rogdi is 
unexpectedly monomeric, unlike most ZIP proteins that exhibit a left-handed parallel dimeric coiled-coil struc-
ture or a higher order oligomer22. The monomeric organization of Rogdi was confirmed in solution by biochem-
ical experiments including size-exclusion chromatography and analytical ultracentrifugation (Fig. 3A and B). 
Although Rogdi does not self-associate through the coiled-coil α domain, a set of predominantly repeated leucine 
residues are buried and involved in forming hydrophobic interfaces in the four-helix bundle structure. Based on 
this observation, we propose that two parallel helical pairs (H1/H3 or H2/H6) arrange into leucine zipper-like 
domains within the Rogdi monomer (Fig. 3C). The hydrophobic side chains of V27, L31, L34, and L38 of H1, and 
those of V142, M146, V149, and L153 of the parallel H3, are oriented towards each other, where they contribute 
to the stabilization of the four-helix bundle structure by forming hydrophobic interactions. Likewise, the hydro-
phobic side chains of I113, A116, V120, and A123 of H2, and those of L254, A257, F261, and S264 of its parallel 
H6, are buried at the interface and involved in hydrophobic interactions. However, the axes of H2 and H6 are not 
Full-length Rogdi tRogdi
Data set: Native Se-SAD
X-ray source Beamline 5C, PAL Beamline 5C, PAL
Temperature (K) 100 100
Space group: R3 P21212
Cell parameters a, b, c (Å)
169.00, 169.00, 220.62 63.36, 114.69, 44.21
90.00, 90.00, 120.00 90.00, 90.00, 90.00
Data processing
Wavelength (Å) 1.00000 0.9794
Resolution (Å) 50-2.80 50-2.04
Rmerge (%)a 6.7 (55.1)* 8.2 (46.9)
I/σ 44.6 (5.7) 49.8 (5.9)
Completeness (%) 99.8 (100.0) 99.9 (99.9)
Redundancy 9.1 (9.2) 9.4 (9.3)
Measured reflections 273212 199950
Unique reflections 30008 21207
Refinement statistics
Data range (Å) 36.17-2.80 34.57-2.04
Reflections 57748 39509
Nonhydrogen atoms 8459 1707
Water molecules 104 170
R.m.s. ∆ bonds (Å)b 0.006 0.004
R.m.s. ∆ angles (°)b 1.239 0.79
R-factor (%)c 21.9 20.1
Rfree (%)c,d 26.8 24.5
Ramachandran plot, residues in
 Most favored regions (%) 90.5 94.4
 Additional allowed regions (%) 8.6 5.1
 Generously allowed regions (%) 0.8 0.0
 Disallowed regions (%) 0.1 0.5
Table 1. Data Collection and Refinement Statistics. *Highest resolution shell is shown in parenthesis. 
aRmerge = 100 × ΣhΣi|Ii(h) − <I(h)> |Σh <I(h)>, where Ii (h) is the ith measurement and <I(h)> is the weighted 
mean of all measurement of I(h) for Miller indices h. bRoot-mean-squared deviation (r.m.s. ∆) from target 
geometries. cR-factor = 100 × Σ|FP − FP(calc)|/Σ FP. dRfree was calculated with 5% of the data.
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parallel, but slightly tilted. In addition to hydrophobic interactions, six hydrogen bonds are present at the surface 
of the amphipathic helices. In particular, the side chains of Glu 26 and Arg 44 from H1 form salt bridges with the 
side chains of Lys 274 and Asp 256 from H6. Furthermore, the side chains of Asp 147 and Gln 152 from H3 form 
H-bonds with the side chains of Lys 272 from H6 and His 119 from H2. Lastly, the side chain of Gln 35 from H1 
forms an H-bond contact with the side chain of Gln 132 from loop between H2 and H3 (Fig. 3D).
In general, the basic ZIP domain interacts with DNA via positively charged motifs located next to the ZIP23. 
However, the crystal structure revealed that Rogdi is likely not a DNA-binding protein, because although it has a 
comparable ZIP structure, it does not have the basic motif for protein-DNA interactions (Fig. 4C). Indirect evi-
dence for DNA binding was from a previous immunostaining study using Rogdi-transfected HEK293 cells, which 
revealed that Rogdi is localized at the nuclear envelope13.
In summary, although Rogdi itself does not self-oligomerize, the α domain adopts a leucine zipper-like struc-
ture in which repeated hydrophobic residues are involved in forming the hydrophobic core of the four-helix 
bundle. Nevertheless, at this point, we cannot exclude the possibility that Rogdi might interact with other proteins 
through the coiled-coil motif of the α domain.
Extended H1 and H6 Helices Mediate Coiled-Coil Protein Interactions. As mentioned earlier, 
crystals of full-length Rogdi revealed two conformations, designated as RogdiH and RogdiL, depending on the 
continuity of H1 helix. Given that the N-terminal residues 1–11 are easily accessible and prone to proteolytic 
degradation, the non-paired region of H1 in the four-helix bundle (residues 1–14) might be flexible in solution. 
This is consistent with the structure of RogdiL, in which H1 helix residues 1–14 are disassociated from the helix 
and form a sharp bend due to steric hindrance by neighboring molecules in the crystal (Fig. 4A). However, this 
region might undergo a conformational change and adopt a helical structure with a parallel helix from a neigh-
boring molecule, as shown in RogdiH (Fig. 4B). The extended H1 helix in RogdiH engages in a parallel coiled-coil 
Figure 2. Crystal Structure of Rogdi. (A) Ribbon diagram showing the structure of full-length Rogdi. The 
protein is composed of two distinct α and β domains. The protein chain is colored blue to red from the N- to 
C-terminus. (B) Topological diagram showing the secondary structural elements and domain organization of 
human Rogdi. Helices and strands are depicted by cylinders and arrows, respectively. (C) Overall structure of 
full-length Rogdi (RogdiH = cyan, RogdiL = orange) and tRogdi (pink) in the same orientation for comparative 
purposes. (D) Close-up view showing residues that contribute to the tight association at the interface between 
the β (cyan) and β (yellow) domains. Oxygen and nitrogen atoms are colored red and blue, respectively. Yellow 
dotted lines indicate intermolecular hydrogen bonds. The Glu 59 residue known as a polymorphism (E59K) in 
human Rogdi is highlighted in red.
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interaction with the adjacent H1 and H6 helices from the other molecule via crystal packing. The interface resi-
dues facing the coiled-coil domain are composed of hydrophobic residues such as Ala 6, Ala 10, Val 14 and Trp 
21 from H1, and Val 259, Tyr 260, Val 263, and Leu 267 from H6. In particular, a highly conserved hydrophobic 
patch comprising Leu 23, Ile 37, Leu 267, and Val 277 from H1 and H6 is exposed to the surface, suggesting that 
the hydrophobic surface generated by helices H1 and H6 could provide a platform for a protein–protein interac-
tion module by conformational changes of the N-terminus into an extended H1 helix (Fig. 4C).
Previous studies using the yeast-two hybrid technique discovered that Rogdi might interact with DISC1 (MIM 
605210), a protein implicated in the development of schizophrenia and involved in cytoskeletal stability and 
organization, neuronal migration, intracellular transport, and cell division13, 17, 18. Future work will be required 
to address whether the extended H1 helix might be involved in interactions with other binding partners such as 
DISC1.
Rogdi Resembles Claudin-15, a major Tight Junctions Component. To obtain insight into the 
molecular functions of Rogdi based on its structure, we searched the Protein Data Bank (PDB) using DALI24, 
and found that full-length Rogdi is most similar to Claudin-15 (Z-score = 8.4), which is a major membrane 
component of tight junctions25. In particular, the structure of Rogdi appears to share four structural features 
with Claudin-15 (Fig. 5A). (i) Claudin-15 is also composed of a characteristic β-sheet fold and a four-helix bun-
dle; (ii) the typical left-handed four-helix bundle of Claudin-15 spans the entire protein chain from the N- to 
the C-terminus, as is the case for the α domain of Rogdi; (iii) the β-strands in the β-sheet are organized in 
an anti-parallel manner and are flanked by a short α-helix; and (iv) the two distinct α and β domains are not 
spatially separated but tightly packed together. Since these structural features are also shared with the Rogdi 
Figure 3. The Leucine Zipper-Like Domain of Rogdi. (A) Size-exclusion chromatography analysis of full-
length and truncated (residues 11–276) Rogdi showing the oligomeric state. Molecular mass standards for 
SEC experiments (top) were aldolase (158 kDa), ovalbumin (44 kDa), carbonic anhydrase (29 kDa) and RNase 
A (13.7 kDa). Chromatography was performed on a Superdex 200 column in buffer containing 25 mM TRIS, 
150 mM NaCl, and 5 mM DTT (pH 7.5). (B) Equilibrium fitting of the results of analytical ultracentrifugation 
for full-length (left) and truncated (right) Rogdi. The lower panel depicts the fitted overlay (red line) to the 
experimental data (blue circles). The upper panel depicts the residuals. (C) Helical wheel representation and 
cartoon diagrams showing the heptad repeat and intermolecular interactions within two parallel helices (H1/
H3, top and H2/H6, bottom) of the Rogdi α domain. (D) Detailed view of the intermolecular hydrogen bonds 
between the surface of amphipathic helices of the α domain. Dotted lines indicate hydrogen bonds (Q35-Q132, 
R159-H119, and H119-Q152) and three ion pairs (see text for details).
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structure, the two proteins could conceivably share similar functions, most likely as scaffolds and/or engaging in 
self-polymerization in tight junctions25. Other than Claudin-15, the full-length Rogdi structure did not share a 
great deal of similarity with any other soluble proteins.
Although the full-length Rogdi structure could only be aligned with Claudin-15, the separate domains could 
be superimposed with pectin methylesterase inhibitor and staphostatin A with an RMSD of 3.3 and 5.7 Å, respec-
tively (Fig. 5B and C). However, we propose that the similarity with these domains does not clearly reflect their 
molecular functions, because the RMSD values do not indicate a close structural similarity, and the two distinct 
domains of Rogdi are not separate but are tightly associated with each other.
The Relationship between Rogdi Mutations and KTS. Extensive genetic analyses have revealed that 
mutations in the ROGDI gene appear to cause KTS. Mutations of Rogdi implicated in KTS are summarized in 
Table 2. All mutations identified to date are frameshift, nonsense, or splice-site mutations that are expected to 
either cause premature mRNA degradation by nonsense-mediated decay, or dramatically alter the protein struc-
ture and thereby cause a complete loss of protein function. In particular, ROGDI c.469 C > T and c.286 C > T 
mutations cause the premature termination of translation at residue 157 and residue 96, respectively14. Residue 
157 is located at the C-terminal end of H3, indicating that this mutant is truncated at the second β-sheet and 
H6. Since H6 is a component of the four-helix bundle in the α domain, the mutant would disrupt both α and β 
domains (Fig. 1A and 6A). Recently, the novel ROGDI homozygous mutation (c.117 + 1 G > T) was identified in 
a patient with KTS15. The mutation abolishes the usual splice donor site of intron 2, which causes the deletion of 
exon 2 and the in-frame assembly of exon 3. Exon 2 encodes a highly conserved 24 amino acid region (residues 
16–39), which corresponds to the central region of H1 (Fig. 1A). Apart from these residues, the mutant protein 
would have no further truncations. Deletion mutations may reduce the length of helix H1 from 45 to 20 amino 
acids, or disrupt the structure of the H1 helix itself. In both cases, mutation would break the hydrophobic core 
responsible for stabilizing the four-helix bundle (Fig. 6B). Based on this hypothesis, we propose that defects in 
the α domain would affect the stability and hence the molecular function of the Rogdi protein, and thereby cause 
Figure 4. Extended H1 and H6 Helices Mediate Protein–Protein Interactions. (A) Crystal contacts of RogdiL in 
the asymmetric unit. Circles indicate the flexible N-terminal helix of RogdiL, which is bent sharply due to steric 
hindrance. The structure of RogdiH (red) is overlaid with that of RogdiL (yellow) for structural comparison and 
to highlight steric hindrance between molecules in the crystal asymmetric unit. (B) Rogdi molecules showing 
crystal contacts (left). The close-up view on the right shows residues that contribute to contact surfaces. Oxygen 
and nitrogen atoms are colored red and blue, respectively. (C) Surface representation of RogdiH. The surface is 
colored according to residue identity (middle) as shown in Fig. 1B, and according to charge distribution (right), 
highlighting the conservation of hydrophobic residues that might be involved in protein–protein interactions.
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KTS. Notably, there are numerous reports demonstrating that the stability of four-helix bundles is essential for 
the structure and function of proteins26–28.
To further investigate the potential importance of the α domain to the stability of the Rogdi protein, we 
generated point mutant constructs (F261A and L271A) to induce interruptions in the hydrophobic core of the 
α domain, and measured protein stability using circular dichroism (CD) spectroscopy. A wavelength scan of 
the mutants showed no significant differences in spectra, suggesting that mutations did not affect the second-
ary structure (Fig. 6C). We determined the folding free energy value of wild-type and mutant Rogdi proteins 
using chemical and thermal denaturation experiments in which the loss of α-helical structure was monitored by 
CD spectroscopy at neutral pH. Surprisingly, the melting temperatures for the F261A and L271A mutants were 
decreased by ~4–5 °C compared with the wild-type protein and a negative control mutant (Q266A), suggesting 
the disruption of the hydrophobic core destabilizes the helical bundle of the α domain and affects the overall pro-
tein stability (Fig. 6D). Consistent with the thermal stability data, all affected mutants exhibited significantly less 
resistance to urea-induced protein denaturation (Fig. 6E).
Most interestingly, although deletion of the N-terminus (residues 16–39) did not affect the CD wavelength 
spectrum, the dramatic disruption of the thermal and chemical stability indicated that the deletion affected the 
protein structure and stability, which might explain the KTS disease-causing phenotype (Fig. 6B–E). It is still 
unknown whether the α domain is involved in protein–protein interactions, and what the molecular functions of 
such interactions might be. However, we believe that the α domain of Rogdi contributes to the overall structure 
and stability, and perturbation of the α domain by mutation likely results in the loss of function and the eventual 
onset of KTS.
Discussion
Rogdi has been predicted to be a leucine zipper protein and a transcription factor. However, our crystal structure 
revealed that the N- and C- termini of Rogdi include periodically repeating leucine residues that contribute to the 
formation of a four-helix bundle structure rather than a typical leucine zipper, although the α domain does adopt 
an internal ZIP-like structure (Fig. 3C). Most importantly, we also found that the N-terminal H1 helix (residues 
Figure 5. Structural Comparison between Rogdi and Claudin-15. Structural comparison of Rogdi and proteins 
with a similar fold, shown in the same orientation. Full-length RogdiH most closely resembles Claudin-15 
(A, PDB ID: 4P79), an essential component of tight junctions. RogdiL shows structural similarity with pectin 
methylesterase inhibitor (B, PDB ID: 1X8Z) and staphostatin A (C, PDB ID: 1OH1).
Type of Mutation Genotype Molecular Phenotype Ref.
Deletion mutation
homozygous for c.229_230del p.Leu77Alafs*64 14
homozygous for c.507delC p.Glu170Argfs*72 16
homozygous for c.46–37_46–30del N/A 16
homozygous for c.45 + 9_45 + 20del p.Glu16Valfs*57 16
Nonsense mutation
homozygous for c.286 C > T p.Gln96* 14
homozygous for c.469 C > T p.Arg157* 13
Duplication and deletion mutation heterozygous for c.366dupA and c.45 + 9_45 + 20del p.Ala123Serfs*19 16
Splicing-site mutation
heterozygous for c.531 + 5 G > C and c.532-2 A > T N/A 14
homozygous for c.117 + 1 G > T 24A.A. deletion from position Glu16 to Lys39 15
Table 2. Summary of KTS-associated ROGDI gene mutations.
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19–45) is paired with the C-terminal H6 helix (residues 252–287) in an anti-parallel manner, indicating that the 
integrity of the four-helix bundle requires both N- and C-terminal residues (Fig. 2B). Thus, truncation mutations 
might seriously affect the overall structure, and cause the protein to be degraded (Fig. 6). Mounting evidence 
suggests mutation of Rogdi is the genetic cause of KTS. In particular, quantitative RT-PCR data from KTS patients 
Figure 6. Mutation of Rogdi affects Structure and Stability. (A) Close-up view of the four-helix bundle 
hydrophobic interface in the α domain of Rogdi. (B) Schematic diagram showing the possible domain 
organization in the c. 117 + 1 G > T mutant15. The red region (residues 16–39) of H1 is deleted in the mutant 
due to a splicing error. (C) Far-UV CD spectra of wild-type and mutant Rogdi scanned from 203 to 260 nm. 
(D) Thermal unfolding curves of wild-type and mutant Rogdi measured by CD spectroscopy. (E) Urea-induced 
unfolding of wild-type and mutant Rogdi39 conducted by monitoring loss of helicity during CD spectroscopy at 
222 nm.
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showed that transcription of Rogdi is lower than in wild-type controls, indicating that mutated transcripts are 
selectively degraded through a nonsense-mediated decay14. In the present study, we further demonstrated that 
even if translation of mutated Rogdi transcripts is completed, the structure of the truncated Rogdi protein is likely 
to be unstable and prone to degradation, based on the crystal structure. The α domain in particular appears to be 
very important for the overall structure and stability, and presumably for mediating protein–protein interactions.
Rogdi appears to share several key structural features with Claudin-15 (Fig. 5A). In addition, it was recently 
reported that Claudin-4 and Claudin-19, which are structurally similar to Claudin-15, interact with a Clostridium 
perfringens enterotoxin via their β-sheet structures, resulting in the disintegration of tight junctions29, 30. Although 
future work is clearly necessary, the β domain of Rogdi might also perform essential molecular functions, such as 
providing a binding platform for interacting partners.
Recently, patients showing atypical KTS phenotypes without any mutations in the ROGDI gene have been 
reported, suggesting that other genes might also cause KTS14, 16, 31. Indeed, according to the report, mutation in 
the SLC13A5 gene, which encodes a sodium-dependent citrate transporter, might also cause KTS32. Moreover, 
the ROGDI gene is reported to play an important role in tumorigenesis and the cell cycle19, 33. However, it has 
not yet been elucidated whether there is a molecular correlation between ROGDI and SLC13A5 in cancerous 
cells. Therefore, further study is needed to expand our understanding of the cellular functions of Rogdi and its 
relationship to KTS phenotypes. Nevertheless, the structural and biochemical results of the present study provide 
structural insight into the relationship between Rogdi and KTS, and this fundamental knowledge might prove 
useful for the development of pharmaceutical agents for the treatment or cure of this debilitating neurological 
disease. Furthermore, the high-resolution structure of Rogdi can be used to confirm or repudiate the potential 
effects of new and potentially pathogenic mutations on Rogdi structure.
Methods
Protein Production. Human full-length (residues 1–287) and truncated (tRogdi, residues 11–276) Rogdi 
proteins were expressed in E. coli BL21(DE3) cells from a modified pET-Duet vector with an N-terminal His6 
tag followed by a TEV protease cleavage site. Cells were lysed in 25 mM sodium phosphate (pH 7.5) contain-
ing 400 mM NaCl and protease inhibitors. After Ni2+ affinity chromatography, the His6 tag was cleaved by 
TEV protease, and the protein was purified further by ion-exchange and gel-filtration chromatography steps. 
Selenomethionine-substituted protein was generated by expressing the tRogdi protein in E. coli B834 (DE3) cells 
(Novagen) using M9 minimal medium plus selenomethionine. The protein was concentrated to ~20 mg/ml by 
centrifugation in 25 mM TRIS-HCl containing 150 mM NaCl and 5 mM DTT (pH 7.5) and flash-frozen in liq-
uid nitrogen for storage. Rogdi mutants were generated using PCR-based methods. All mutants were overex-
pressed at room temperature in the same E. coli host as glutathione S-transferase (GST) fusion proteins using 
the pGEX-6P1 vector (GE Healthcare). To increase the solubility of the deletion mutant, we co-expressed with 
bacterial GroESL chaperone proteins. The GST-Rogdi mutants were purified using glutathione S-sepharose and 
cleaved by PreScission protease (GE healthcare). Mutant proteins were purified further by cation-exchange chro-
matography on a HiTrap SP column and by gel-filtration chromatography on a Superdex 200 column.
Crystallization and Structure Determination by SAD. Human tRogdi protein was crystallized at 4 °C 
by the hanging-drop vapor diffusion method by adding 1 μl of a 9 mg/ml protein solution to 1 μl of well solution 
comprising 11% PEG 4 K, 100 mM MES pH 6.5, and 5 mM DTT. The resultant orthogonal crystals belong to 
space group P21212 (a = 63.4 Å, b = 114.7 Å, c = 44.2 Å) and contain one molecule in the asymmetric unit. For 
X-ray diffraction experiments, crystals were transferred to well solution containing 30% glycerol and flash-frozen 
in liquid nitrogen. Single-wavelength anomalous diffraction (SAD) data were collected from a Se-Met crystal at 
beamline 5 C of the Pohang Accelerator Laboratory (PAL) and processed using HKL-2000 software34. SAD data 
analysis was performed using Phenix35 software using data between 50 and 2.04 Å resolution. Phenix found eight 
of the nine selenium sites and refined them to a mean figure-of-merit of 0.38. Electron density modification using 
RESOLVE software36 yielded an initial electron density map of excellent quality. Successive rounds of model 
building and refinement were performed using Coot and Phenix, respectively35, 37. The final model contains one 
tRogdi monomer in the asymmetric unit. Residues 11 to 23, 47 to 56, 64 to 68, 92 to 96, 130 to 138, and 266 were 
not modelled due to weak electron density.
For full-length Rogdi crystals, protein solution (1 μl) was mixed with an equal volume of 2 M sodium chloride, 
130 mM magnesium chloride, and 100 mM TRIS pH 7.0. Crystals (space group R3; a = b = 169.0 Å, c = 220.6 Å) 
grew within 1 week at 4 °C. For diffraction experiments, crystals were transferred to well solution containing an 
additional 30% glycerol and flash-frozen in liquid nitrogen. X-ray diffraction data were collected at the same PAL 
beamline and processed as described above. The structure was solved by molecular replacement using Phaser38 
with the tRogdi structure as the search model. An initial model of tRogdi was improved by rigid-body and posi-
tional refinement, and the structure was built into the resulting electron density map. Final refinement yielded 
an R-factor of 21.9% (Rfree = 26.8%) for data between 35 and 2.8 Å resolution (Table 1). The final model consists 
of 8459 protein atoms and contains four copies of Rogdi in the asymmetric unit. Of these, the following residues 
were not modelled due to weak electron density: Residues 48 to 55, 211, 235, and 286 to 287 in the first copy; 
residues 48 to 55, 211, and 286 to 287 in the second copy; residues 48 to 56, 64 to 68, 92 to 96, 212 to 221, and 284 
to 287 in the third copy; residues 48 to 56, 64 to 68, 94 to 96, 181, 212 to 221, and 284 to 287 in the fourth copy. 
Structure analyses and molecular visualization were performed using PYMOL program (www.pymol.org). The 
refinement statistics and composition of the final models are summarized in Table 1.
CD Spectroscopy. The secondary structure of Rogdi mutants were monitored using a CD spectrometer 
(Jasco J-815) with wavelength scans from 190 to 260 nm. Possible conformational changes were also monitored 
by CD spectroscopy at various temperatures by raising the temperature from 25 to 85 °C over a 5 min period, with 
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detection at 222 nm. All samples were prepared in 25 mM TRIS pH 7.5, 150 mM NaCl, 5 mM β-mercaptoethanol, 
pH 7.5. For chemical denaturation, protein samples were mixed with 0 to 8 M urea, incubated for 5 h at room 
temperature, and measured at 222 nm on the same CD spectrometer.
Unfolding Titration for Determination of Folding Free Energy. To determine the folding free energy 
of Rogdi proteins, we assumed that all proteins had folded and unfolded states that were dependent on the con-
centration of urea, and that the two states were reversible, as summarized in the following expressions:
Unfolded protein folded protein (1)
In the reaction (1), the folding constant, KF, was calculated from the following formula:
=K [F]/[U] (2)F
where [F] is the concentration of the folded protein, and [U] is the concentration of the unfolded protein. Each 
concentration can be expressed in terms of the total protein concentration (Pt) and the fraction unfolded (fU). 
Equation (2) can be expressed in terms of Pt and fU as follows:
= − ∗
= −
∗
f
K P (1 f )/(P f )
(1 f )/ (3)
F t U t U
U U
The fraction unfolded is then calculated from the observed ellipticity ([θ]) as follows:
θ θ θ θ= − −f ([ ] [ ] )/([ ] [ ] ) (4)U F U F
The [θ]F is the ellipticity of the fully folded protein, and [θ]U is the ellipticity of the fully unfolded protein. The 
free energy of the protein is calculated using the following formula:
∆ = −G RT ln(K ) (5)F
where R is the gas constant and T is the absolute temperature. The free energy of the protein can then be calcu-
lated depending on the concentration of urea ([urea]). To determine the folding free energy of the protein (ΔG°), 
ΔG and [Urea] are fitted to a y = ax + b plot using the following:
∆ = + ∆ °G m[urea] G (6)
where m is the slope, and ΔG is the folding free energy when the concentration of urea is zero.
Analytical Ultracentrifugation. The molecular mass of human full-length and truncated Rogdi was 
analyzed by analytical ultracentrifugation (Optima XL-A; Beckman) using the sedimentation equilibrium 
technique. For sedimentation equilibrium analytical ultracentrifugation, protein samples were prepared in 
buffer containing 25 mM TRIS-HCl (pH 7.5), 150 mM NaCl, and 5 mM β-mercaptoethanol at concentrations 
of 10 μM, 15 μM, and 20 μM. Data were evaluated using a nonlinear least-squares curve-fitting algorithm 
in the XL-A data analysis software. For equilibrium analysis, scans obtained at equilibrium using multiple 
speeds (10000, 20000 and 30000 rpm) were collected at 15 °C using an An-60 Ti rotor (Beckman) by measur-
ing the absorbance at 280 nm. Measurements were fitted to a single species model using Origin 6.03 software 
(Beckman Coulter, Inc.).
Sequence Analysis. For sequence alignment (Fig. 1C), Rogdi sequences from six organisms were aligned: 
Homo sapiens (NP_078865), Mus musculus (NP_573448), Xenopus laevis (AAH94137), Caenorhabditis elegans 
(NP_498641), Danio rerio (NP_956257), and Drosophila melanogaster (NP_648956).
Limited Proteolysis. Limited proteolysis experiments were carried out to define domain boundaries. 
Full-length Rogdi was digested with trypsin using a range of protein concentrations and incubation times at 4 °C. 
The reaction was stopped with 1 mM PMSF, and products were analyzed by SDS-PAGE and N-terminal protein 
sequencing.
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Figure S1. Stereo images of full-length RogdiH 
(A) The stereo view shows the backbone trace of full-length RogdiH. The residues 4856, 
6468, 9496, 181, and 212221 are disordered and indicated by blue, cyan green, yellow, and 
orange stars, respectively.  
(B) The 2.8 Å  resolution 2Fo-Fc electron density (contoured at 1σ) of the H1 in the α domain 
was shown with a final model to represent the quality of structural data. 
